OR WAIT null SECS
February 23, 2018
The contract development and manufacturing organization has entered it first manufacturing contract worth $148 million for its recently completed Plant 3 facility.
February 20, 2018
The study suggests that circumventing evolution in cell factories can enable the commercialization of new biobased chemicals to large-scale.
February 14, 2018
Ferring Pharmaceuticals will expand its biologics capabilities at its headquarters and manufacturing site in Saint-Prex, Switzerland.
February 07, 2018
Through its Janssen pharmaceutical companies, Johnson & Johnson, has partnered with Theravance to develop and commercialize a therapeutic for inflammatory bowel diseases.
February 02, 2018
Experts share insights on the various methods used for purity and impurity analysis of therapeutic proteins.
Regulations and industry guidelines focus on ensuring excipient safety by specifying risk assessments and shared responsibility.
February 01, 2018
Cambrex invests in development and laboratory facilities and adds staff.
Avista Pharma's strengthens early phase drug development offerings with acquisition of Solid Form Solutions.
Chemical engineers and chemists each bring unique skills to API process development and optimization. Success depends on their close collaboration, at both sponsor and CDMO facilities.
January 31, 2018
The new Acquity Arc Bio System by Waters is specifically engineered to enable efficient transfer and improvement of bioseparation analytical methods.
